Evidence map›Paper›PMID 38265846›Full record

ArticleJMIR public health and surveillance2024

Assessing Global, Regional, and National Time Trends and Associated Risk Factors of the Mortality in Ischemic Heart Disease Through Global Burden of Disease 2019 Study: Population-Based Study.

Tingting Shu, Ming Tang, Bo He, Xiaozhu Liu, Yu Han, Chang Liu, Pedro A Jose, Hongyong Wang, Qing-Wei Zhang, Chunyu Zeng

Abstract read
In one paragraph

Article in JMIR public health and surveillance, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. American heart journal plus : cardiology research and practice · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Tingting ShuDepartment of Cardiology, Daping Hospital, The Third Military Medical University (Army Medical University), Chongqing, China.ORCID 0000-0002-0778-4915
Ming TangDepartment of Cardiology, Daping Hospital, The Third Military Medical University (Army Medical University), Chongqing, China.ORCID 0000-0003-1587-2584
Bo HeDepartment of Cardiology, Daping Hospital, The Third Military Medical University (Army Medical University), Chongqing, China.ORCID 0000-0002-5597-0413
Xiaozhu LiuDepartment of Critical Care Medicine, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.ORCID 0000-0001-7419-3480
Yu HanDepartment of Cardiology, Daping Hospital, The Third Military Medical University (Army Medical University), Chongqing, China.ORCID 0000-0003-1418-6814
Chang LiuDepartment of Cardiac Surgery, Daping Hospital, The Third Military Medical University (Army Medical University), Chongqing, China.ORCID 0000-0002-6479-1839
Pedro A JoseDivision of Renal Diseases and Hypertension, The George Washington University School of Medicine and Health Sciences, Washington, DC, United States.ORCID 0000-0003-1507-7556
Hongyong WangDepartment of Cardiology, Daping Hospital, The Third Military Medical University (Army Medical University), Chongqing, China.ORCID 0000-0002-6045-0842
Qing-Wei Zhang *Division of Gastroenterology and Hepatology, Key Laboratory of Gastroenterology and Hepatology, Ministry of Health, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai Institute of Digestive Disease, Shanghai, China.ORCID 0000-0001-6908-049X
Chunyu Zeng *Department of Cardiology, Daping Hospital, The Third Military Medical University (Army Medical University), Chongqing, China.ORCID 0009-0004-8317-5400

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIschemic heart disease (IHD) is the leading cause of death among noncommunicable diseases worldwide, but data on current epidemiological patterns and associated risk factors are lacking.

objectiveThis study assessed the global, regional, and national trends in IHD mortality and attributable risks since 1990.

methodsMortality data were obtained from the Global Burden of Disease 2019 Study. We used an age-period-cohort model to calculate longitudinal age curves (expected longitudinal age-specific rate), net drift (overall annual percentage change), and local drift (annual percentage change in each age group) from 15 to >95 years of age and estimate cohort and period effects between 1990 and 2019. Deaths from IHD attributable to each risk factor were estimated on the basis of risk exposure, relative risks, and theoretical minimum risk exposure level.

resultsIHD is the leading cause of death in noncommunicable disease-related mortality (118.1/598.8, 19.7%). However, the age-standardized mortality rate for IHD decreased by 30.8% (95% CI -34.83% to -27.17%) over the past 30 years, and its net drift ranged from -2.89% (95% CI -3.07% to -2.71%) in high sociodemographic index (SDI) region to -0.24% (95% CI -0.32% to -0.16%) in low-middle-SDI region. The greatest decrease in IHD mortality occurred in the Republic of Korea (high SDI) with net drift -6.06% (95% CI -6.23% to -5.88%), followed by 5 high-SDI nations (Denmark, Norway, Estonia, the Netherlands, and Ireland) and 2 high-middle-SDI nations (Israel and Bahrain) with net drift less than -5.00%. Globally, age groups of >60 years continued to have the largest proportion of IHD-related mortality, with slightly higher mortality in male than female group. For period and birth cohort effects, the trend of rate ratios for IHD mortality declined across successive period groups from 2000 to 2004 and birth cohort groups from 1985 to 2000, with noticeable improvements in high-SDI regions. In low-SDI regions, IHD mortality significantly declined in female group but fluctuated in male group across successive periods; sex differences were greater in those born after 1945 in middle- and low-middle-SDI regions and after 1970 in low-SDI regions. Metabolic risks were the leading cause of mortality from IHD worldwide in 2019. Moreover, smoking, particulate matter pollution, and dietary risks were also important risk factors, increasingly occurring at a younger age. Diets low in whole grains and legumes were prominent dietary risks in both male and female groups, and smoking and high-sodium diet mainly affect male group.

conclusionsIHD, a major concern, needs focused health care attention, especially for older male individuals and those in low-SDI regions. Metabolic risks should be prioritized for prevention, and behavioral and environmental risks should attract more attention to decrease IHD mortality.

Indexed as

Global Burden of DiseaseSmokingAdolescentAdultAgedAged, 80 and overFemaleHealth FacilitiesHumansMaleMiddle AgedResearchRisk FactorsYoung Adultage-period-cohort analysisGBD 2019Global Burden of Disease 2019 studyischemic heart diseasemortalityrisk factors

Identifiers

PMID38265846
PMCPMC10851120

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.